Avanos Medical, Inc. Income Statement
AVNS / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Avanos Medical, Inc. reported $701M in revenue and $73M in net loss for FY2025. Revenue has declined at a 6.5% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $701.2M | $687.8M | $673.3M | $684.1M | $587.0M | $714.8M | $697.6M | $652.3M | $611.6M | $566.2M | $509.0M | $1.7B | $1.7B | $1.7B |
| Cost of Revenue | $347.3M | $306.5M | $293.6M | $289.9M | $287.8M | $343.9M | $295.4M | $261.4M | $274.7M | $269.0M | $251.2M | $1.1B | $1.1B | $1.1B |
| Gross Profit | $353.9M | $381.3M | $379.7M | $394.2M | $299.2M | $370.9M | $402.2M | $390.9M | $336.9M | $297.2M | $257.8M | $548.6M | $612.2M | $602.5M |
| SG&A Expense | $315.6M | $318.5M | $335.0M | $326.5M | $285.3M | $332.6M | $399.1M | $340.4M | $321.7M | $346.2M | $349.7M | $424.5M | $351.4M | $343.0M |
| R&D Expense | $23.3M | $26.2M | $27.2M | $29.2M | $30.6M | $34.9M | $37.7M | $41.8M | $38.2M | $38.4M | $27.6M | $33.6M | $37.9M | $33.0M |
| Operating Income | -$61.6M | -$396.2M | $4.2M | $35.5M | -$39.0M | -$48.5M | -$55.7M | $500.0K | -$43.1M | -$107.1M | -$135.7M | $94.3M | $225.3M | $228.0M |
| Interest Expense | - | - | $15.0M | $10.0M | $3.3M | $15.6M | $15.0M | $26.4M | $31.6M | $32.7M | $33.1M | $6.0M | $100.0K | $800.0K |
| Income Tax | $6.7M | -$17.0M | $2.0M | $5.2M | -$11.2M | -$33.9M | -$18.1M | -$9.6M | -$40.1M | -$55.9M | -$67.3M | $64.1M | $73.2M | $77.2M |
| Net Income | -$72.9M | -$392.1M | -$61.8M | $50.5M | $6.3M | -$29.0M | -$45.9M | $57.5M | $79.3M | $39.8M | -$426.3M | $27.1M | $154.6M | $152.6M |
| EPS (Basic) | -$1.32 | $1.08 | $0.13 | -$0.61 | -$0.96 | $1.22 | $1.69 | $0.85 | -$9.15 | $0.58 | $3.32 | $3.28 | $3.32 | $3.28 |
| EPS (Diluted) | -$1.32 | $1.07 | $0.13 | -$0.61 | -$0.96 | $1.22 | $1.69 | $0.85 | -$9.15 | $0.58 | $3.32 | $3.28 | $3.32 | $3.28 |
| Shares Outstanding | 46.0M | 46.2M | 46.5M | 48.2M | 47.9M | 47.7M | 47.4M | 46.9M | 46.7M | 46.6M | 46.5M | 46.5M | 46.5M | - |
| Gross Margin | 50.5% | 55.4% | 56.4% | 57.6% | 51.0% | 51.9% | 57.6% | 59.9% | 55.1% | 52.5% | 50.6% | 32.8% | 36.5% | 35.8% |
| Operating Margin | -8.8% | -57.6% | 0.6% | 5.2% | -6.6% | -6.8% | -8.0% | 0.1% | -7.0% | -18.9% | -26.7% | 5.6% | 13.4% | 13.5% |
| Profit Margin | -10.4% | -57.0% | -9.2% | 7.4% | 1.1% | -4.1% | -6.6% | 8.8% | 13.0% | 7.0% | -83.8% | 1.6% | 9.2% | 9.1% |